Volcano Capital

Total investments

9

Average round size

4M

Portfolio companies

9

Rounds per year

0.60

Lead investments

1

Exits

2

Stages of investment
SeedEarly Stage Venture
Areas of investment
BiotechnologyAnalyticsInformation TechnologyHealth CareHealth DiagnosticsWellnessManufacturingMedical DeviceMedicalProduct Design

Summary

In 2009 was created Volcano Capital, which is appeared as VC. The main department of described VC is located in the New York. The venture was found in North America in United States.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Volcano Capital, startups are often financed by U.S. Department of the Treasury, Palo Alto Investors, Kevin Farnham. The meaningful sponsors for the fund in investment in the same round are FCA Venture Partners, Crocker Capital, Clayton Associates. In the next rounds fund is usually obtained by SalubrisBio.

Among the various public portfolio startups of the fund, we may underline MediQuire, Mercator MedSystems We can highlight the next thriving fund investment areas, such as Analytics, Medical Device. The fund has no exact preference in some founders of portfolio startups. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

The usual things for fund are deals in the range of 5 - 10 millions dollars. The high activity for fund was in 2016. The fund is generally included in less than 2 deals every year.

Show more

Investments analytics

Analytics

Total investments
9
Lead investments
1
Exits
2
Rounds per year
0.60
Investments by industry
  • Medical (6)
  • Health Care (6)
  • Medical Device (5)
  • Health Diagnostics (2)
  • Biotechnology (2)
  • Show 11 more
Investments by region
  • United States (7)
  • China (1)
  • Israel (1)
Peak activity year
2010

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
16
Avg. valuation at time of investment
8M
Group Appearance index
0.56
Avg. company exit year
20
Avg. multiplicator
9.38

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Health Biotech 23 Dec 2020 Biotechnology, Medical Device, Medical Early Stage Venture 15M Beijing, Changping, China

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.